SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report [amend]
SEC Accession No. 0001193125-11-270527
Filing Date
2011-10-13
Accepted
2011-10-13 16:05:33
Documents
1
Period of Report
2011-06-02
Filing Date Changed
2011-10-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A d242966d8ka.htm 8-K/A 12655
  Complete submission text file 0001193125-11-270527.txt   13763
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33415 | Film No.: 111139789
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1